[Federal Register Volume 67, Number 58 (Tuesday, March 26, 2002)]
[Notices]
[Pages 13770-13771]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-7158]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-32]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Symptoms Associated with the Convalescent Period 
of a Dengue Infection--New--National Center for Infectious Diseases 
(NCID), Centers for Disease Control and Prevention (CDC).
    Dengue is a vector-borne febrile disease of the tropics transmitted 
most often by the mosquito Aedes aegypti. Symptoms of the acute disease 
include fever, headache, rash, retro-orbital pain, myalgias, 
arthralgias, vomiting, abdominal pain and hemorrhagic manifestations.
    Many symptoms are mentioned in the medical literature as associated 
with the convalescent period (3-8 weeks) after dengue infection, 
including depression, dementia, loss of sensation, paralysis of lower 
and upper extremities and larynx, epilepsy, tremors, manic psychosis, 
amnesia, loss of visual acuity, hair loss, and peeling of skin. No 
epidemiologic study has been conducted to define the timing, frequency 
and risk factors for these symptoms. The objective of this study is to 
examine the incidence and characteristics of mental health disorders 
and other complications associated with dengue infection and 
convalescence.
    The study will be conducted in Puerto Rico, where dengue is endemic 
and causes severe sporadic epidemics. Laboratory positive confirmed 
cases of dengue, laboratory negative suspected dengue cases and 
neighborhood controls will be prospectively enrolled in the study. 
Person-to-person interviews with adults (age 18 years or greater) will 
be conducted and information will be collected regarding symptoms 
experienced during the convalescent phase of the infection. There are 
no costs to respondents.

----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of        burden/      Total burden
                   Respondents                      respondents     responses/     response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Laboratory positive confirmed dengue............             200               2               1             400
Dengue negative control.........................             200               2               1             400
Neighborhood control............................             200               2               1             400
Total...........................................  ..............  ..............  ..............            1200
----------------------------------------------------------------------------------------------------------------



[[Page 13771]]

    Dated: March 18, 2002.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-7158 Filed 3-25-02; 8:45 am]
BILLING CODE 4163-18-P